7-7969480-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138426.4(GLCCI1):c.130G>A(p.Gly44Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,005,110 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00163 AC: 226AN: 138438Hom.: 1 Cov.: 30
GnomAD4 exome AF: 0.000133 AC: 115AN: 866588Hom.: 0 Cov.: 28 AF XY: 0.000121 AC XY: 49AN XY: 404894
GnomAD4 genome AF: 0.00167 AC: 232AN: 138522Hom.: 2 Cov.: 30 AF XY: 0.00188 AC XY: 127AN XY: 67594
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.130G>A (p.G44S) alteration is located in exon 1 (coding exon 1) of the GLCCI1 gene. This alteration results from a G to A substitution at nucleotide position 130, causing the glycine (G) at amino acid position 44 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at